Skip to main content
Clinical Trials/ACTRN12619000221156
ACTRN12619000221156
Recruiting
Phase 4

Comparison of continuous infusion against programmed intermittent bolus of local anaesthesia through adductor canal catheter after total knee arthroplasty.

Counties Manukau Health, Middlemore Hospital Research Office0 sites72 target enrollmentFebruary 14, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pain relief after Total Knee Arthroplasty
Sponsor
Counties Manukau Health, Middlemore Hospital Research Office
Enrollment
72
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Counties Manukau Health, Middlemore Hospital Research Office

Eligibility Criteria

Inclusion Criteria

  • We aim to enrol patients undergoing primary TKA in our institution prior to the day of surgery in the preadmission clinic or on the day of surgery at the time of surgical and anaesthetic consent. Adequate time for patient questions and a plain language explanation sheet will be provided to aid patient consent. The study will be completed at Middlemore Hospital and Manukau Surgical Centre.

Exclusion Criteria

  • Refusal or inability to consent.
  • Analgesic technique involving epidural or peripheral nerve blockade (single shot or continuous techniques)
  • Nerve catheter placed outside accepted range (distal to femoral triangle down to the adductor canal)
  • Allergies to medication used in the study or its constituents
  • Significant kidney and liver dysfunction (CrCl \< 30mls/min, AST/ALT \>2x upper limit of normal)
  • Surgical procedure performed outside of Counties Manukau Health facilities.
  • Failure to site adductor canal catheter in the appropriate location.
  • Patients on \>30mg/day of oral morphine equivalent for any reason.
  • Patients outside the specified age range of 18\-80 years.
  • Patients at extremes of weight e.g.\<50kg or \>150kg

Outcomes

Primary Outcomes

Not specified

Similar Trials